Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2011, Article ID 381787, 11 pages
http://dx.doi.org/10.1155/2011/381787
Research Article

Pulmonary Hypertension Related to Left-Sided Cardiac Pathology

Division of Cardiology, Duke University Medical Center, P.O. Box 3102, Durham, NC 27710, USA

Received 10 January 2011; Revised 2 April 2011; Accepted 2 April 2011

Academic Editor: Aldo T. Iacono

Copyright © 2011 Todd L. Kiefer and Thomas M. Bashore. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. V. McLaughlin, S. L. Archer, D. B. Badesch et al., “ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association Developed in Collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association,” Journal of the American College of Cardiology, vol. 53, no. 17, pp. 1573–1619, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. N. Gali, M. M. Hoeper, M. Humbert et al., “Guidelines for the diagnosis and treatment of pulmonary hypertension,” European Heart Journal, vol. 30, no. 20, pp. 2493–2537, 2009. View at Publisher · View at Google Scholar · View at PubMed
  3. S. Ghio, A. Gavazzi, C. Campana et al., “Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure,” Journal of the American College of Cardiology, vol. 37, no. 1, pp. 183–188, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Grigioni, L. Potena, N. Galiè et al., “Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure,” Journal of Heart and Lung Transplantation, vol. 25, no. 10, pp. 1241–1246, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. S. P. Lam, V. L. Roger, R. J. Rodeheffer, B. A. Borlaug, F. T. Enders, and M. M. Redfield, “Pulmonary hypertension in heart failure with preserved ejection fraction. A community-based study,” Journal of the American College of Cardiology, vol. 53, no. 13, pp. 1119–1126, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. C. Walls, N. Cimino, S. F. Bolling, and D. S. Bach, “Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome?” The Journal of Heart Valve Disease, vol. 17, no. 1, pp. 1–9, 2008. View at Google Scholar
  7. R. A. Krasuski, J. J. Warner, A. Wang, J. K. Harrison, V. F. Tapson, and T. M. Bashore, “Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology,” Journal of the American College of Cardiology, vol. 36, no. 7, pp. 2204–2211, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Krasuski, A. Wang, J. K. Harrison, V. F. Tapson, and T. M. Bashore, “The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use,” American Heart Journal, vol. 150, no. 4, pp. 725–728, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. D. Montani, D. S. O'Callaghan, L. Savale et al., “Pulmonary veno-occlusive disease: recent progress and current challenges,” Respiratory Medicine, vol. 104, supplement 1, pp. S23–S32, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Palazzini and A. Manes, “Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension,” European Respiratory Review, vol. 18, no. 113, pp. 177–180, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. Montani, L. Achouh, P. Dorfmüller et al., “Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology,” Medicine, vol. 87, no. 4, pp. 220–233, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. O. Bonow, B. A. Carabello, K. Chatterjee et al., “2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease),” Journal of the American College of Cardiology, vol. 52, no. 13, pp. e1–e142, 2008. View at Publisher · View at Google Scholar · View at PubMed
  13. W. Feldman TaG, “Profiles in valvular heart disease,” in Grossman's Cardiac Catheterization, Angiography, and Intervention, D. S. Baim, Ed., pp. 637–638, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2006. View at Google Scholar
  14. G. Snopek, H. Pogorzelska, T. M. Rywik, A. Browarek, J. Janas, and J. Korewicki, “Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty,” American Journal of Cardiology, vol. 90, no. 2, pp. 188–189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Levine, J. S. Weinstein, D. J. Diver et al., “Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty,” Circulation, vol. 79, no. 5, pp. 1061–1067, 1989. View at Google Scholar · View at Scopus
  16. P. A. Ribeiro, M. A. Zaibag, and M. Abdullah, “Pulmonary artery pressure and pulmonary vascular resistance before and after mitral balloon valvotomy in 100 patients with severe mitral valve stenosis,” American Heart Journal, vol. 125, no. 4, pp. 1110–1114, 1993. View at Publisher · View at Google Scholar
  17. J. S. Hung, M. S. Chern, J. J. Wu et al., “Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy,” American Journal of Cardiology, vol. 67, no. 9, pp. 854–862, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Dev and S. Shrivastava, “Time course of changes in pulmonary vascular resistance and the mechanism of regression of pulmonary arterial hypertension after balloon mitral valvuloplasty,” American Journal of Cardiology, vol. 67, no. 5, pp. 439–442, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Ward and B. W. Hancock, “Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery,” British Heart Journal, vol. 37, no. 1, pp. 74–78, 1975. View at Google Scholar · View at Scopus
  20. E. Braunwald, N. S. Braunwald, J. Ross Jr., and A. G. Morrow, “Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension,” The New England Journal of Medicine, vol. 273, pp. 509–514, 1965. View at Google Scholar
  21. J. E. Dalen, J. M. Matloff, G. L. Evans et al., “Early reduction of pulmonary vascular resistance after mitral-valve replacement,” The New England Journal of Medicine, vol. 277, no. 8, pp. 387–394, 1967. View at Google Scholar · View at Scopus
  22. J. J. Morgan, “Hemodynamics one year following mitral valve replacement,” The American Journal of Cardiology, vol. 19, no. 2, pp. 189–195, 1967. View at Google Scholar · View at Scopus
  23. T. Zielinski, H. Pogorzelska, A. Rajecka, A. Biedermavn, M. Sliwinski, and J. Korewicki, “Pulmonary hemodynamics at rest and effort, 6 and 12 months after mitral valve replacement: a slow regression of effort pulmonary hypertension,” International Journal of Cardiology, vol. 42, no. 1, pp. 57–62, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. D. K. Tempe, S. Hasija, V. Datt et al., “Evaluation and comparison of early hemodynamic changes after elective mitral valve replacement in patients with severe and mild pulmonary arterial hypertension,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 23, no. 3, pp. 298–305, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. K. Fattouch, F. Sbraga, G. Bianco et al., “Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement,” Journal of Cardiac Surgery, vol. 20, no. 2, pp. 171–176, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. F. Santini, G. Casali, G. Franchi et al., “Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults,” International Journal of Cardiology, vol. 103, no. 2, pp. 156–163, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. G. Healy, D. Veerasingam, J. McHale, and D. Luke, “Successful perioperative utilisation on inhaled nitric oxide in mitral valve surgery,” Journal of Cardiovascular Surgery, vol. 47, no. 2, pp. 217–220, 2006. View at Google Scholar · View at Scopus
  28. N. Yurtseven, P. Karaca, G. Uysal et al., “A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery,” Annals of Thoracic and Cardiovascular Surgery, vol. 12, no. 5, pp. 319–323, 2006. View at Google Scholar · View at Scopus
  29. S. Rex, G. Schaelte, S. Metzelder et al., “Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial,” Acta Anaesthesiologica Scandinavica, vol. 52, no. 1, pp. 65–72, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. D. McGoon and G. C. Kane, “Pulmonary hypertension: diagnosis and management,” Mayo Clinic Proceedings, vol. 84, no. 2, pp. 191–207, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. R. V. Shah and M. J. Semigran, “Pulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and management,” Current Heart Failure Reports, vol. 5, no. 4, pp. 226–232, 2008. View at Google Scholar · View at Scopus
  32. C. G. Elliott and H. I. Palevsky, “Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis,” Thorax, vol. 59, no. 6, pp. 536–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Bomma, H. O. Ventura, G. Daniel, and H. Patel, “Adjunctive sildenafil for the treatment of pulmonary hypertension after mitral valve replacement,” Congestive Heart Failure, vol. 12, no. 6, pp. 347–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. W. Johnson, M. B. Hapanowicz, C. Buonanno, M. A. Bowser, M. A. Marvasti, and F. B. Parker, “Pulmonary hypertension in isolated aortic stenosis. Hemodynamic correlations and follow-up,” Journal of Thoracic and Cardiovascular Surgery, vol. 95, no. 4, pp. 603–607, 1988. View at Google Scholar · View at Scopus
  35. K. Silver, G. Aurigemma, S. Krendel, N. Barry, I. Ockene, and J. Alpert, “Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism,” American Heart Journal, vol. 125, no. 1, pp. 146–150, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Faggiano, F. Antonini-Canterin, F. Ribichini et al., “Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis,” American Journal of Cardiology, vol. 85, no. 2, pp. 204–208, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Casaclang-Verzosa, V. T. Nkomo, M. E. Sarano, J. F. Malouf, F. A. Miller, and J. K. Oh, “E/Ea is the major determinant of pulmonary artery pressure in moderate to severe aortic stenosis,” Journal of the American Society of Echocardiography, vol. 21, no. 7, pp. 824–827, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. N. Kapoor, P. Varadarajan, and R. G. Pai, “Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis,” European Journal of Echocardiography, vol. 9, no. 1, pp. 31–33, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. J. F. Malouf, M. Enriquez-Sarano, P. A. Pellikka et al., “Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications,” Journal of the American College of Cardiology, vol. 40, no. 4, pp. 789–795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. R. G. Pai, P. Varadarajan, N. Kapoor, and R. C. Bansal, “Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension,” Annals of Thoracic Surgery, vol. 84, no. 1, pp. 80–85, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. S. Khandhar, P. Varadarajan, R. Turk et al., “Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension,” Annals of Thoracic Surgery, vol. 88, no. 3, pp. 752–756, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. D. P. Naidoo, A. S. Mitha, S. Vythilingum, and S. Chetty, “Pulmonary hypertension in aortic regurgitation: early surgical outcome,” Quarterly Journal of Medicine, vol. 80, no. 291, pp. 589–595, 1991. View at Google Scholar · View at Scopus
  43. B. P. Shapiro, M. D. McGoon, and M. M. Redfield, “Unexplained pulmonary hypertension in elderly patients,” Chest, vol. 131, no. 1, pp. 94–100, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. B. A. Borlaug, R. A. Nishimura, P. Sorajja, C. S. P. Lam, and M. M. Redfield, “Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction,” Circulation: Heart Failure, vol. 3, no. 5, pp. 588–595, 2010. View at Publisher · View at Google Scholar · View at PubMed
  45. S. A. Hunt, W. T. Abraham, M. H. Chin et al., “2009 focused update incorporated Into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation,” Journal of the American College of Cardiology, vol. 53, no. 15, pp. e1–e90, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People with Diastolic Heart Failure (The RELAX Study), 2010, http://clinicaltrials.gov/ct2/show/NCT00763867?term=relax&rank=00763861.
  47. M. Guglin and H. Khan, “Pulmonary hypertension in heart failure,” Journal of Cardiac Failure, vol. 16, no. 6, pp. 461–474, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. F. L. Dini, R. Nuti, L. Barsotti, U. Baldini, R. Dell'Anna, and G. Micheli, “Doppler-derived mitral and pulmonary venous flow variables are predictors of pulmonary hypertension in dilated cardiomyopathy,” Echocardiography, vol. 19, no. 6, pp. 457–465, 2002. View at Google Scholar · View at Scopus
  49. R. J. Cody, G. J. Haas, P. F. Binkley, Q. Capers, and R. Kelley, “Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure,” Circulation, vol. 85, no. 2, pp. 504–509, 1992. View at Google Scholar · View at Scopus
  50. C. M. Wei, A. Lerman, R. J. Rodeheffer et al., “Endothelin in human congestive heart failure,” Circulation, vol. 89, no. 4, pp. 1580–1586, 1994. View at Google Scholar · View at Scopus
  51. S. V. Abramson, J. F. Burke, J. J. Kelly et al., “Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy,” Annals of Internal Medicine, vol. 116, no. 11, pp. 888–895, 1992. View at Google Scholar · View at Scopus
  52. T. P. Cappola, G. M. Felker, W. H. L. Kao, J. M. Hare, K. L. Baughman, and E. K. Kasper, “Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk,” Circulation, vol. 105, no. 14, pp. 1663–1668, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Kjaergaard, D. Akkan, K. K. Iversen et al., “Prognostic importance of pulmonary hypertension in patients with heart failure,” American Journal of Cardiology, vol. 99, no. 8, pp. 1146–1150, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. J. F. Delgado, M. A. Gomez-Sanchez, C. Saenz de la Calzada et al., “Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation,” Journal of Heart and Lung Transplantation, vol. 20, no. 9, pp. 942–948, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. Mehra, J. Kobashigawa, R. Starling et al., “Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006,” Journal of Heart and Lung Transplantation, vol. 25, no. 9, pp. 1024–1042, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. A. Costard-Jackle and M. B. Fowler, “Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group,” Journal of the American College of Cardiology, vol. 19, no. 1, pp. 48–54, 1992. View at Google Scholar · View at Scopus
  57. M. Zakliczynski, M. Maruszewski, L. Pyka et al., “Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates,” Transplantation Proceedings, vol. 39, no. 9, pp. 2856–2858, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. J. Martin, M. P. Siegenthaler, O. Friesewinkel et al., “Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation—a preliminary study,” European Journal of Cardio-Thoracic Surgery, vol. 25, no. 6, pp. 971–977, 2004. View at Publisher · View at Google Scholar · View at PubMed
  59. S. P. Salzberg, M. L. Lachat, K. von Harbou, G. Zünd, and M. I. Turina, “Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates,” European Journal of Cardio-Thoracic Surgery, vol. 27, no. 2, pp. 222–225, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. H. Liden, A. Haraldsson, S.-E. Ricksten, U. Kjellman, and L. Wiklund, “Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?” European Journal of Cardio-Thoracic Surgery, vol. 35, no. 6, pp. 1029–1035, 2009. View at Publisher · View at Google Scholar · View at PubMed
  61. A. C. Alba, V. Rao, H. J. Ross et al., “Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients,” Journal of Heart and Lung Transplantation, vol. 29, no. 11, pp. 1253–1258, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. E. Mikus, A. Stepanenko, T. Krabatsch et al., “Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients,” European Journal of Cardio-thoracic Surgery. In Press. View at Publisher · View at Google Scholar · View at PubMed
  63. R. John, K. Liao, F. Kamdar, P. Eckman, A. Boyle, and M. Colvin-Adams, “Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices,” Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 2, pp. 447–452, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. R. M. Califf, K. F. Adams, W. J. McKenna et al., “A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST),” American Heart Journal, vol. 134, no. 1, pp. 44–54, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. P. I. Anand, P. J. McMurray, P. J. N. Cohn et al., “Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 364, no. 9431, pp. 347–354, 2004. View at Publisher · View at Google Scholar · View at PubMed
  66. M. Packer, J. McMurray, B. M. Massie et al., “Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study,” Journal of Cardiac Failure, vol. 11, no. 1, pp. 12–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. W. S. Colucci, U. Elkayam, D. P. Horton et al., “Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure,” The New England Journal of Medicine, vol. 343, no. 4, pp. 246–253, 2000. View at Publisher · View at Google Scholar · View at PubMed
  68. M. R. Mehra, H. O. Ventura, C. Kapoor, D. D. Stapleton, D. Zimmerman, and F. W. Smart, “Safety and clinical utility of long-term intravenous milrinone in advanced heart failure,” American Journal of Cardiology, vol. 80, no. 1, pp. 61–64, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. G. D. Lewis, R. Shah, K. Shahzad et al., “Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension,” Circulation, vol. 116, no. 14, pp. 1555–1562, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M. D. Guazzi, “Long-term use of sildenafil in the therapeutic management of heart failure,” Journal of the American College of Cardiology, vol. 50, no. 22, pp. 2136–2144, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus